Latest News

Journal Articles

Autoimmune

Could hyaluronic acid contribute to chronic white matter injury?

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Cerebrovascular disease

Hypertension drug increases cerebral blood flow in people with Alzheimer’s, study suggests

Regenerative stroke therapies: an interview with Steven Cramer

Stroke recovery: could the microbiome be a new therapeutic option?

CNS/PNS/SNS

Nerve transfer surgery restores hand and arm function

EAN 2019: Neural clock and internal ‘GPS’ may provide valuable insights into Alzheimer’s disease

New technology generates synthetic speech using brain activity

Cognitive/neurodegenerative disorders

Phase II/III trials of umibecestat to discontinue for Alzheimer’s disease: industry news round-up

AAIC 2019: Why is Alzheimer’s disease more prevalent in women? Sex-specific differences reported

AAIC 2019: Are we one step closer to finding a blood test for Alzheimer’s?

Demyelinating disease

EAN 2019: Does multiple sclerosis increase risk of developing cancer?

Multiple sclerosis: determining the dynamic nature of oligodendrocyte regeneration

Biomarker discovery and development in multiple sclerosis: where are we now?

Development and pediatrics

Spinraza®: positive long-term data reported in pre-symptomatic infants

Is exercise the newest way to re-tune brain structure in mice with autism spectrum disorder?

Autism linked to mutations in ‘junk’ DNA and not specific genes, study reveals

Epilepsy and seizure

WHO releases first global report on epilepsy

tRNAs: a blood-based biomarker for predicting seizures?

Children’s brains remap and retain visual perception after surgery for severe epilepsy

Genetics

Early-onset Alzheimer’s disease linked to high LDL cholesterol levels

Autism linked to mutations in ‘junk’ DNA and not specific genes, study reveals

Ask the Experts: Gene therapies in neurological diseases (Part II: challenges and future outlooks)

Headache

Acute migraine: novel therapy shows promise in Phase III trial

Why are migraines more common in women? New sex-specific insights revealed

US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up

Immune disorders and inflammation

Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?

FENS 2018: Immune system offers new way of treating Alzheimer’s disease

FENS 2018: Could anxiety and inflammation be treated with cannabis?

Infection

Could a bacterial polysaccharide suppress fatal brain inflammation?

Link between Alzheimer’s disease and periodontal bacteria gains traction

ANA 2018: key highlights and news stories

Injury/trauma

Nerve transfer surgery restores hand and arm function

Can inflammatory biomarkers predict recovery time after concussion?

Signs of hidden consciousness detected after brain injury

Movement disorders

A peek behind the paper – Sarah Hamm-Alvarez on oligomeric α-synuclein in basal tears of Parkinson’s patients

Parkinson’s: new mouse model supports gut–brain connection

Study reveals possible early signs of Parkinson’s in the brain

Neuro-ophthalmology

Gene therapy breakthrough allows mice to regain sight

Could an eye scan detect signs of Alzheimer's disease?

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Neuropsychiatry

Addiction: a compulsive interplay between drugs, cues and habits

Galanin identified as new therapeutic target for the treatment of depression

Brain ‘fingerprinting’: a whole-system perspective into psychiatric conditions

Oncology/tumor

Risk of Alzheimer’s may be raised by hormone therapy for prostate cancer

EAN 2019: Does multiple sclerosis increase risk of developing cancer?

Depatux-M fails to meet primary endpoint in late-stage trial for newly diagnosed glioblastoma

Pain

Acute migraine: novel therapy shows promise in Phase III trial

Why are migraines more common in women? New sex-specific insights revealed

Could neuropathic pain be treated by modulation of immune cells?

Sleep

AAIC 2019: Sleep medications may increase dementia risk depending on race and gender

AAIC 2019: How can sleep disruption be improved in individuals with dementia?

Late-life Alzheimer’s pathology may be predicted with sleep history